Low-dose short-course metformin decrease the risk of atherosclerosis in the non-obese prediabetic individuals

Background: The establishment of macrovascular (cardiovascular) event is initiated in the period of prediabetic. Metformin plays role in the carbohydrate and lipid metabolism as well as vascular protection. The mechanism of the cardiovascular event risk increased in the pre-diabetic individual has n...

Full description

Saved in:
Bibliographic Details
Main Author: Perpustakaan UGM, i-lib
Format: Article NonPeerReviewed
Published: [Yogyakarta] : Universitas Gadjah Mada 2008
Subjects:
Online Access:https://repository.ugm.ac.id/27441/
http://i-lib.ugm.ac.id/jurnal/download.php?dataId=10500
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Universitas Gadjah Mada
id id-ugm-repo.27441
record_format dspace
spelling id-ugm-repo.274412014-06-18T00:24:58Z https://repository.ugm.ac.id/27441/ Low-dose short-course metformin decrease the risk of atherosclerosis in the non-obese prediabetic individuals Perpustakaan UGM, i-lib Jurnal i-lib UGM Background: The establishment of macrovascular (cardiovascular) event is initiated in the period of prediabetic. Metformin plays role in the carbohydrate and lipid metabolism as well as vascular protection. The mechanism of the cardiovascular event risk increased in the pre-diabetic individual has not been clearly established. Objective: The study was to determine if insulin resistance control by low-dose short-course metformin administration in the non-obese prediabetic individual might decrease the risk of atherosclerosis. Methods: It was a prospective experimental double blind study with pretest-posttest control group design. It was conducted on the first degree relatives of type-2 Diabetes Mellitus patients who met the criteria of non-obese prediabetic individuals. Subjects were randomly classified into treatment group (designed for metformin administration), and the control group (designed for placebo administration). The prediction of atherosclerosis risk was based on the hsCRP, PAI-1, VCAM-1, and fibrinogen levels. Result: The results showed that the margin between pre- and post-metformin administration term were 1.89 vs. 0.06 mg/L (p=0.001), 1.42 vs. 0.84 IU/mL (p=0.0151. 180.85 vs. 03.81 mg/L (p=0.061) and 80.15 vs. 31.42 mg/dL (p=0.001) for hsCRP, PAI-1, VCAM-1, and Fibrinogen levels in the treatment and control group, respectively. Conclusion: The study concluded that the low-dose short-course metformin administration might decrease the atherosclerosis risk significantly in the non-obese prediabetic individuals. Key words: metformin - non-obese prediabetics - hsCRP - PAI-T- Fibrinogen - VCAM-T [Yogyakarta] : Universitas Gadjah Mada 2008 Article NonPeerReviewed Perpustakaan UGM, i-lib (2008) Low-dose short-course metformin decrease the risk of atherosclerosis in the non-obese prediabetic individuals. Jurnal i-lib UGM. http://i-lib.ugm.ac.id/jurnal/download.php?dataId=10500
institution Universitas Gadjah Mada
building UGM Library
country Indonesia
collection Repository Civitas UGM
topic Jurnal i-lib UGM
spellingShingle Jurnal i-lib UGM
Perpustakaan UGM, i-lib
Low-dose short-course metformin decrease the risk of atherosclerosis in the non-obese prediabetic individuals
description Background: The establishment of macrovascular (cardiovascular) event is initiated in the period of prediabetic. Metformin plays role in the carbohydrate and lipid metabolism as well as vascular protection. The mechanism of the cardiovascular event risk increased in the pre-diabetic individual has not been clearly established. Objective: The study was to determine if insulin resistance control by low-dose short-course metformin administration in the non-obese prediabetic individual might decrease the risk of atherosclerosis. Methods: It was a prospective experimental double blind study with pretest-posttest control group design. It was conducted on the first degree relatives of type-2 Diabetes Mellitus patients who met the criteria of non-obese prediabetic individuals. Subjects were randomly classified into treatment group (designed for metformin administration), and the control group (designed for placebo administration). The prediction of atherosclerosis risk was based on the hsCRP, PAI-1, VCAM-1, and fibrinogen levels. Result: The results showed that the margin between pre- and post-metformin administration term were 1.89 vs. 0.06 mg/L (p=0.001), 1.42 vs. 0.84 IU/mL (p=0.0151. 180.85 vs. 03.81 mg/L (p=0.061) and 80.15 vs. 31.42 mg/dL (p=0.001) for hsCRP, PAI-1, VCAM-1, and Fibrinogen levels in the treatment and control group, respectively. Conclusion: The study concluded that the low-dose short-course metformin administration might decrease the atherosclerosis risk significantly in the non-obese prediabetic individuals. Key words: metformin - non-obese prediabetics - hsCRP - PAI-T- Fibrinogen - VCAM-T
format Article
NonPeerReviewed
author Perpustakaan UGM, i-lib
author_facet Perpustakaan UGM, i-lib
author_sort Perpustakaan UGM, i-lib
title Low-dose short-course metformin decrease the risk of atherosclerosis in the non-obese prediabetic individuals
title_short Low-dose short-course metformin decrease the risk of atherosclerosis in the non-obese prediabetic individuals
title_full Low-dose short-course metformin decrease the risk of atherosclerosis in the non-obese prediabetic individuals
title_fullStr Low-dose short-course metformin decrease the risk of atherosclerosis in the non-obese prediabetic individuals
title_full_unstemmed Low-dose short-course metformin decrease the risk of atherosclerosis in the non-obese prediabetic individuals
title_sort low-dose short-course metformin decrease the risk of atherosclerosis in the non-obese prediabetic individuals
publisher [Yogyakarta] : Universitas Gadjah Mada
publishDate 2008
url https://repository.ugm.ac.id/27441/
http://i-lib.ugm.ac.id/jurnal/download.php?dataId=10500
_version_ 1681218960291266560